MCTA
NASDAQ · Diversified Consumer Services

Charming Medical Ltd-A

$29.36
+1.86 (+6.75%)
Financial Highlights (FY 2026)
Revenue
6.22M
Net Income
1.20M
Gross Margin
99.7%
Profit Margin
19.3%
Rev Growth
D/E Ratio
8.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.7% 46.5% 46.5% 46.5%
Operating Margin 22.3% 21.4% 20.1% 20.3%
Profit Margin 19.3% 13.3% 15.5% 14.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.22M 135.41M 140.27M 135.21M
Gross Profit 6.20M 62.93M 65.18M 62.83M
Operating Income 1.39M 28.94M 28.19M 27.46M
Net Income 1.20M 18.04M 21.77M 19.82M
Gross Margin 99.7% 46.5% 46.5% 46.5%
Operating Margin 22.3% 21.4% 20.1% 20.3%
Profit Margin 19.3% 13.3% 15.5% 14.7%
Rev Growth +23.2% +24.3% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 222.96M 29.01M 24.84M 31.62M
Total Equity 25.65M 293.22M 293.71M 340.85M
D/E Ratio 8.69 0.10 0.08 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 1.65M 33.84M 36.03M 35.10M
Free Cash Flow 25.60M 16.06M 17.94M